Join Growin Stock Community!
Beta
Back to LLY.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • P/E Ratio
  • P/S Ratio
  • P/B Ratio
  • EV/EBITDA
  • EV/Sales
  • PE Ratio River
ev-to-ebitda-chart

LLY EV/EBITDA

EV/EBITDA

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for LLY's EV/EBITDA ratio in Q1'26 stands at 93.63, marking a substantial increase from the previous quarter's value of 36.60 in Q4'25 and indicating heightened market valuation relative to earnings before interest, taxes, depreciation, and amortization. Over the period from Q2'23 to Q1'26, the EV/EBITDA ratio exhibited an initial upward trend, rising sharply from 58.45 in Q2'23 to a peak of 90.47 in Q4'23, before entering a prolonged decline to a low of 34.06 in Q3'25, reflecting potential market corrections or improved operational efficiency. This downward trajectory persisted with minor fluctuations, such as a slight rebound to 36.60 in Q4'25, until the abrupt surge in Q1'26, suggesting renewed investor optimism or sector-specific catalysts in the pharmaceutical industry. Overall, the area chart highlights a volatile pattern with a net recovery in the most recent quarter, warranting close monitoring for sustainability.